LISA Fine Textile, a textile dermatitis manufacturer based in New Jersey, was found guilty of falsely advertising that it had a cure for fine textile allergies.

The trial, which was held in the Northern District of New Jersey and heard testimony from multiple experts, included testimony from former president of LISA, David H. Fuchs, who said Fine Textil had been a “key partner” in his career.

In his testimony, Fuchs said he “never had any idea” Fine Textils products had a claim that they could cure fine textil allergies.

“I never really understood the value of a business that was making such claims,” Fuchs testified.

The jury deliberated for just over three hours before finding LISA guilty of making false claims and false advertising.

The verdict was delivered on March 2, 2019.

Fine Textiles’ products were promoted as a cure and the company’s website claimed that Fine Texts products could be used to treat all types of allergies.

The company even had a website that advertised its products as a solution for fine print allergies.

In reality, Fine Textilt’s products only targeted the most sensitive skin types and they did not provide any information on what type of allergies they could be cured from.

Fine Print Textile was also not accredited by any governmental body and had not received any government funding.

The fine print in the company website claimed to contain “proof” that Fine Print Textiles products were safe for people who have allergies.

According to a news release, the jury found LISA’s “misleading marketing” amounted to willful misconduct and “serious harm.”

Fine Textile pleaded guilty to a $5 million fine.

The judge also ordered that the company be required to pay the government $1 million for any losses it sustained as a result of the false advertising and false advertisements.